CN101229336B - External used medicine for treating chronic eczema - Google Patents
External used medicine for treating chronic eczema Download PDFInfo
- Publication number
- CN101229336B CN101229336B CN2008100011068A CN200810001106A CN101229336B CN 101229336 B CN101229336 B CN 101229336B CN 2008100011068 A CN2008100011068 A CN 2008100011068A CN 200810001106 A CN200810001106 A CN 200810001106A CN 101229336 B CN101229336 B CN 101229336B
- Authority
- CN
- China
- Prior art keywords
- portions
- medicine
- treatment
- stubborn dermatitis
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to the medical technical field, in particular to an external-using medicine used for the treatment of stubborn dermatitis, which is prepared by mixing and soaking the following raw materials, and the raw materials expressed by weight account comprise: 80-120 portions of stemona root, 80-120 portions of stemona root, 80-120 portions of zanthoxylum pipertum DC, 30-70 portions of chaulmoogra, 30-70 portions of wild aconite root, 30-70 portions of sulfur, 3-8 portions of salicylic acid and 60-80 portions of ethanol. The external-using medicine used for the treatment of the stubborn dermatitis of the invention has new, advanced and unique raw material formula, and organically combined traditional Chinese medicines with western medicines. Furthermore, the invention has simple processing technique and applying method, innocuity and no side effect, fast drug effect and high cure rate.
Description
Technical field
The present invention relates to medical technical field, particularly relate to a kind of medicine for the treatment of stubborn dermatitis.
Background technology
Stubborn dermatitis class disease is common a kind of multiple cutaneous disease, many because virus, cell hyperplasia, pigmentation are had a low resistance etc. and to be caused, have characteristics such as sickness rate height, course of disease length, the difficulty of curing, easy recurrence, have a strong impact on people's healthy and quality of life.Stubborn dermatitis comprises psoriasis, neurodermatitis, tinea corporis, tinea cruris, tinea versicolor, tinea manus and pedis etc.
At present, the medicine and the method for treatment stubborn dermatitis are of a great variety, and the doctor trained in Western medicine external lays particular emphasis on bactericidal antiphlogistic, for oral administration then many, hormones quick and so on medicine with breath, its shortcoming is that therapeutic effect is relatively poor, easily repeatedly, drug side effect is big, and is heavier to human body skin damnification, often leaves cicatrix; Chinese traditional treatment is many, and the course of treatment is longer based on damp and hot dampness, dispelling wind for relieving itching, and how not obvious curative effect is, and do not reach the effect of radical cure.
Summary of the invention
In view of above defective, the invention provides a kind of medicine for external use for the treatment of stubborn dermatitis, this medicine is at the pathogenic factors of stubborn dermatitis, adopt anti-inflammation, heat clearing away cold expelling, promoting blood circulation to restore menstrual flow network, the hypochondriac lump of loosing, be mainly to fill a prescription blood circulation and the influential Chinese herbal medicine of smooth muscle, and " five convenience " of considering people's disease preventing and treating be designed to externally applied liniment, but the various stubborn dermatitis of rapid healing.
In order to reach above purpose, the medicine for external use of this kind treatment stubborn dermatitis provided by the invention mixes immersion by following raw material and makes, and described raw material is represented to comprise with parts by weight:
The Radix Stemonae 80～120;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 80～120;
Fructus Zanthoxyli 80～120;
Semen Hydnocarpi 30～70;
Radix Aconiti Kusnezoffii 30～70;
Sulfur 30～70;
Salicylic acid 3～8;
Ethanol 60～80.
The medicine for external use of this kind treatment stubborn dermatitis provided by the invention, the optimization formula of described raw material is (parts by weight):
The Radix Stemonae 100;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100;
Fructus Zanthoxyli 100;
Semen Hydnocarpi 50;
Radix Aconiti Kusnezoffii 50;
Sulfur 50;
Salicylic acid 5;
Ethanol 75.
The medicine for external use of this kind treatment stubborn dermatitis provided by the invention, another optimization formula of described raw material is (parts by weight):
The Radix Stemonae 80;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 120;
Fructus Zanthoxyli 100;
Semen Hydnocarpi 40;
Radix Aconiti Kusnezoffii 70;
Sulfur 30;
Salicylic acid 3;
Ethanol 80.
The medicine for external use of this kind treatment stubborn dermatitis provided by the invention, an optimization formula again of described raw material is (parts by weight):
The Radix Stemonae 120;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100;
Fructus Zanthoxyli 80;
Semen Hydnocarpi 40;
Radix Aconiti Kusnezoffii 50;
Sulfur 60;
Salicylic acid 7;
Ethanol 65.
Wherein, the soak time of described raw material is preferably two weeks; It is 75% aqueous solution that described ethanol is configured to concentration expressed in percentage by volume.
The using method of this medicine for external use is to smear the affected part every day 2 to 4 times.
Compared with prior art, advantage of the present invention is:
1, composition of raw materials novelty of the present invention, advanced person, uniqueness organically combine Chinese medicine and Western medicine, make the cooperative compensating effect of every kind of medicine of its performance;
2, this medical instrument has stronger surface activity, acts on skin surface and produces effects rapidly, and curative effect is obvious, and has no side effect;
3, safe in utilization, convenient drug administration, cure rate height, indication extensively, lasting medicine.
The specific embodiment
For making the purpose, technical solutions and advantages of the present invention clearer, the present invention is described in further detail below in conjunction with specific embodiment:
Embodiment 1
Take by weighing raw material according to following prescription:
The Radix Stemonae 100;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100;
Fructus Zanthoxyli 100;
Semen Hydnocarpi 50;
Radix Aconiti Kusnezoffii 50;
Sulfur 50;
Salicylic acid 5;
Ethanol 75.
Promptly obtain finished product after mix soaking two weeks then, smear the patient affected part 3 to 4 every day during clinical use, and curative effect is excellent.
Embodiment 2
Take by weighing raw material according to following prescription:
The Radix Stemonae 80;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 120;
Fructus Zanthoxyli 100;
Semen Hydnocarpi 40;
Radix Aconiti Kusnezoffii 70;
Sulfur 30;
Salicylic acid 3;
Ethanol 80.
Promptly obtain finished product after mix soaking two weeks then, smear the patient affected part 3 to 4 every day during clinical use, and curative effect is excellent.
Embodiment 3
Take by weighing raw material according to following prescription:
The Radix Stemonae 120;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100;
Fructus Zanthoxyli 80;
Semen Hydnocarpi 40;
Radix Aconiti Kusnezoffii 50;
Sulfur 60;
Salicylic acid 7;
Ethanol 65.
Promptly obtain finished product after mix soaking two weeks then, smear the patient affected part 3 to 4 every day during clinical use, and curative effect is excellent.
Below more in conjunction with the embodiments the clinical practice of 1 obtained medicine record effect of the present invention is described:
1, patient's data
Patient on probation is totally 30 examples, male's 18 examples wherein, and women's 12 examples, on the disease kind distributes, neurodermatitis, tinea faciei patient 13 examples, tinea corporis patient's 12 examples, tinea manus and pedis patient 5 examples;
2, using method
Illing skin is cleaned and to be dried, and gets that this medicine is smeared and gently rubs with the hands to absorbing every day 2-4 time fully;
3, observed result
| The sick kind | The example number | Cure more than 90% | Cure more than 70% | Cure more than 50% | Cure below 50% |
| Neurodermatitis, tinea faciei | 13 | 1 | 4 | 8 | 0 |
| Tinea corporis | 12 | 2 | 3 | 7 | 0 |
| Tinea manus and pedis | 5 | 1 | 2 | 2 | 0 |
4, untoward reaction
Individual patient has the local skin irritant reaction, disappears voluntarily after the drug withdrawal;
5, interpretation of result
This medicine has the function of curing various stubborn dermatitis, and various viruses are had the elimination inhibitory action, eliminates the epithelial cell hyperplasia keratinization pigment that disappears, and recovers the function that normal epithelium cell forms level and smooth epidermal tissue.
Below its summary of the invention has been done to elaborate.For persons skilled in the art, any conspicuous change of under the prerequisite that does not deviate from the principle of the invention it being done can not exceed the protection domain of the application's claims.
Claims (6)
1. a medicine for external use for the treatment of stubborn dermatitis is characterized in that, is mixed to soak by following raw material and makes, and described raw material is represented with parts by weight:
The Radix Stemonae 80～120;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 80～120;
Fructus Zanthoxyli 80～120;
Semen Hydnocarpi 30～70;
Radix Aconiti Kusnezoffii 30～70;
Sulfur 30～70;
Salicylic acid 3～8;
Ethanol 60～80.
2. a kind of medicine for external use for the treatment of stubborn dermatitis according to claim 1 is characterized in that the optimization formula of described raw material is expressed as with parts by weight:
The Radix Stemonae 100;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100;
Fructus Zanthoxyli 100;
Semen Hydnocarpi 50;
Radix Aconiti Kusnezoffii 50;
Sulfur 50;
Salicylic acid 5;
Ethanol 75.
3. a kind of medicine for external use for the treatment of stubborn dermatitis according to claim 1 is characterized in that the optimization formula of described raw material is expressed as with parts by weight:
The Radix Stemonae 80;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 120;
Fructus Zanthoxyli 100;
Semen Hydnocarpi 40;
Radix Aconiti Kusnezoffii 70;
Sulfur 30;
Salicylic acid 3;
Ethanol 80.
4. a kind of medicine for external use for the treatment of stubborn dermatitis according to claim 1 is characterized in that the optimization formula of described raw material is expressed as with parts by weight:
The Radix Stemonae 120;
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100;
Fructus Zanthoxyli 80;
Semen Hydnocarpi 40;
Radix Aconiti Kusnezoffii 50;
Sulfur 60;
Salicylic acid 7;
Ethanol 65.
5. according to any described a kind of medicine for external use for the treatment of stubborn dermatitis in the claim 1～4, it is characterized in that the soak time of described raw material is preferably two weeks.
6. according to any described a kind of medicine for external use for the treatment of stubborn dermatitis in the claim 1～4, it is characterized in that the using method of the medicine for external use of described treatment stubborn dermatitis is to smear the affected part every day 3 to 4 times.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100011068A CN101229336B (en) | 2008-01-15 | 2008-01-15 | External used medicine for treating chronic eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100011068A CN101229336B (en) | 2008-01-15 | 2008-01-15 | External used medicine for treating chronic eczema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101229336A CN101229336A (en) | 2008-07-30 |
| CN101229336B true CN101229336B (en) | 2011-04-06 |
Family
ID=39896349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100011068A Expired - Fee Related CN101229336B (en) | 2008-01-15 | 2008-01-15 | External used medicine for treating chronic eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101229336B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108524886A (en) * | 2018-05-28 | 2018-09-14 | 陈雨薇 | A kind of tinea of feet and hands drug paste and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098914A (en) * | 1993-08-14 | 1995-02-22 | 陈兰君 | Effective tinea corporis medicine |
| CN101045142A (en) * | 2006-03-27 | 2007-10-03 | 陈红燕 | Medicine for treating foot tinea and hand tinea |
-
2008
- 2008-01-15 CN CN2008100011068A patent/CN101229336B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098914A (en) * | 1993-08-14 | 1995-02-22 | 陈兰君 | Effective tinea corporis medicine |
| CN101045142A (en) * | 2006-03-27 | 2007-10-03 | 陈红燕 | Medicine for treating foot tinea and hand tinea |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101229336A (en) | 2008-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101721665A (en) | Medicinal liquor for promoting blood circulation and removing blood stasis | |
| CN101732642B (en) | Medicament for treating flat wart | |
| CN1326550C (en) | Quick acting analgetic Chinese medicine liquid | |
| CN1325110C (en) | Medicated wine for treating traumatic injury | |
| CN101229336B (en) | External used medicine for treating chronic eczema | |
| CN103142794B (en) | Paste for drawing out pus to remove sore | |
| CN102716210A (en) | Traditional Chinese medicine for treating rheumatism and production method thereof | |
| CN105267800A (en) | Traditional Chinese medicine ointment for preventing and treating fungal skin diseases of livestock and poultry | |
| CN102743608B (en) | A kind of traumatology Chinese medicine plaster | |
| CN105920250A (en) | Wet ointment for treating rheumatism bone disease | |
| CN101940652B (en) | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus | |
| CN105055800A (en) | Plant compound gel for treating chloasma and preparation method thereof | |
| CN104940811A (en) | External Chinese herba preparation for treating traumatic injury and relieving pain, and preparation method thereof | |
| CN103041071A (en) | Chinese medicinal liniment for treating alopecia areata, alopecia and skin exfoliation itching | |
| CN102114238A (en) | Ointment for treating herpes zoster and preparation method thereof | |
| CN109908213A (en) | It is a kind of for treating the external application Chinese medicine material paste of pain of neck, shoulder, waist and leg | |
| CN104161818A (en) | External preparation for treating lumbar muscle strain | |
| CN102247580A (en) | Medicinal liquor for treating rheumatism, osteoproliferation and old injury | |
| CN101181574B (en) | Chinese vetch strip containing natural aromatic plant | |
| CN107441216A (en) | A kind of formula of medicated bath and its compounding method for preventing heart infarction cerebral infarction cerebral hemorrhage | |
| CN101716231A (en) | Hair growth lotion for treating alopecia areata by external application | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101607069B (en) | Chinese traditional medicine for treating phlebitis, old lower extremity venous ulcer and venous purpura disease | |
| CN101361825B (en) | Traditional Chinese medicine formulation for treating alopecia | |
| CN105233187A (en) | External use finish treating breast diseases and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110406 Termination date: 20140115 |